Chuck Royce's MRVI Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 1.71 M shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $5.54 M, representing 0.06% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in MRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 514,332 shares. Largest reduction occurred in Q3 2022, reducing 458,788 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Maravai LifeSciences Holdings (MRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -55,615 | Reduce 3.16% | 1.71 M | $3.25 |
| Q3 2025 | +484,908 | Add 37.98% | 1.76 M | $2.87 |
| Q2 2025 | -51,588 | Reduce 3.88% | 1.28 M | $2.41 |
| Q1 2025 | +369,559 | Add 38.54% | 1.33 M | $2.21 |
| Q4 2024 | +50,107 | Add 5.51% | 958,885 | $5.45 |
| Q3 2024 | +514,332 | Add 130.39% | 908,778 | $8.31 |
| Q2 2024 | +378,009 | Add 2299.74% | 394,446 | $7.16 |
| Q1 2024 | +16,437 | New Buy | 16,437 | $8.67 |
| Q1 2023 | -54,106 | Sold Out | 0 | $0.00 |
| Q4 2022 | +54,106 | New Buy | 54,106 | $14.31 |
| Q3 2022 | -458,788 | Sold Out | 0 | $0.00 |
| Q2 2022 | +109,303 | Add 31.28% | 458,788 | $28.41 |
| Q1 2022 | +349,485 | New Buy | 349,485 | $35.27 |
Chuck Royce's Maravai LifeSciences Holdings Investment FAQs
Chuck Royce first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2022, acquiring 349,485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Maravai LifeSciences Holdings, Inc. (MRVI) for 13 quarters since Q1 2022.
Chuck Royce's largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q3 2024, adding 908,778 shares worth $7.55 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 1,706,149 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $5.54 M.
As of the Q4 2025 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.06% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 1,761,764 shares, as reported at the end of Q3 2025.